• Imperial College London Diabetes Centre (ICLDC) recognised for its research excellence with ninestudies published in prestigious international journals in 2024
• ICLDC research has identified a new potential biomarker for predicting Type 2 diabetes and its complications
• ICLDC designated as an ‘Active Research Site’ by the Department of Health – Abu Dhabi for its dedication to medical research excellence

Dr. Nader Lessan, Consultant Endocrinologist and Clinical Lead for Research at Imperial College London Diabetes Centre,

Abu Dhabi, United Arab Emirates; August14, 2024:Imperial College London Diabetes Centre (ICLDC), part of the M42 group, announces a series of significant achievements in diabetes treatment and research. This year, nine ICLDC-authored research has been published in high-impact peer-reviewed international journals ,solidifying its status as a global leader in diabetes research.

Continue reading M42’s Imperial College London Diabetes Centre leads the way in diabetes innovation and research →